Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-09

Clinical Trial Update: Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial investigating apatinib as maintenance therapy after first-line chemotherapy in patients with postoperative recurrence or metastasis of gastric ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apatinib (apatinib)

Snippet

Sponsor: Hebei Medical University | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: UNKNOWN